CD38 and acute lymphoblastic leukemia: Thus, it can be inferred that the presentation of lower CD38 expression in the patients analyzed in our B-ALL cohort might be associated with lower activation features on B-cells and lower immunosuppressive capacity of Treg cells, or greater cell maturation, although better understanding of these intricacies is still needed.